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Abstract
Background
The recent obesity epidemic in children also showed an increase in the prevalence of hyper-
tension. As blood pressure (BP) is associated with (long-chain) polyunsaturated fatty acids
(LC PUFA), genetic variation in desaturase enzymes being involved in the synthesis of LC
PUFA may be associated with BP. This study aimed to investigate the direct effects (indepen-
dent of mediating variables) and indirect effects (mediated through intermediate variables) of
a common variant in the FADS1 gene, rs174546, known to affect delta-5 desaturase (D5D)
activity on PUFA level, body mass index (BMI) and BP.
Methods
A subsample of the IDEFICS (Identification and prevention of dietary- and lifestyle-induced
health effects in children and infants) baseline survey including 520 children aged 2 to <10
years from six European countries was included. The association between rs174546 (T<C)
and BP z-score as well as the mediating effects of selected key PUFA levels (dihomo-gamma-
linolenic acid, DGLA; arachidonic acid, ARA; eicosapentaenoic acid, EPA) or estimated D5D
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activity (D5D index) and BMI z-score were investigated through path model analyses,
adjusting for sex, age, educational level of parents, family history of hypertension, lifestyle
factors and blood levels of saturated and monounsaturated fatty acids, triglycerides and
low density lipoprotein cholesterol. Whole blood fatty acids were measured by a validated
gas chromatographic method and recorded as percentage of weight of all fatty acids
detected.
Results
Minor allele carriers of the SNP rs174546 had significantly higher DGLA and lower ARA and
EPA levels as well as a lower D5D index. Via ARA and BMI z-score, the polymorphism had
an indirect lowering effect on systolic BP z-score for each additional T allele (standardized
effect estimate -0.057, p = 0.007). For DGLA, EPA and D5D index, the indirect effects of
rs174546 on systolic BP were also negative but did not reach significance. DGLA and EPA
had an increasing indirect effect on systolic BP via BMI. Results for diastolic BP were in gen-
eral similar but effect estimates were lower compared to systolic BP.
Conclusion
Genetic variation in FADS1 influences BP via ARA and BMI indicating a favorable effect of
the minor allele in SNP rs174546. Thus, polymorphisms with an impact on the D5D activity
may play a role for the BP level mediated through PUFA and BMI. Therefore, health effects
of dietary n-6 and n-3 PUFA may vary depending on genetic FADS1 variants.
Introduction
Blood pressure levels and the prevalence of hypertension are increasing in children and adoles-
cents, particularly because of the epidemic of overweight and obesity already observed in
young age groups [1, 2]. Blood and tissue levels of polyunsaturated fatty acids (PUFA), in par-
ticular long-chain (LC) PUFA have been shown to be associated with blood pressure (BP).
Furthermore, circulating levels of n-3 LC PUFA were associated with a lower prevalence of
hypertension [3, 4]. LC PUFA levels depend on dietary intake, bioavailability and PUFA
metabolism. In the biosynthesis of LC PUFA from precursor PUFA, elongase and desaturase
enzymes are crucial. FADS1, a member of the fatty acid (FA) desaturase gene cluster, codes for
the enzyme delta-5 desaturase (D5D) which is involved in one step of the conversion of linoleic
acid (LA, 18:2n-6) and alpha-linoleneic acid (ALA, 18:3n-3) to arachidonic acid (ARA, 20:4n-
6) and eicosapentaenoic acid (EPA, 20:5n-3), respectively. Genetic variation in desaturases has
shown to affect PUFA and LC PUFA tissue status and studies indicate that polymorphisms in
this gene cluster also influence health outcomes like the lipoprotein profile and the risk of car-
diovascular diseases [5]. Accordingly, estimated D5D activity (D5D index), calculated from
the FA product/precursor ratio (20:4n-6/20:3n-6) was observed to be inversely associated with
BMI [6–8] and BP [6, 9]. Thus, high D5D activity may be protective against adiposity and
hypertension both of which are increasingly prevalent already in children and adolescents [10,
11] and tend to track into adulthood [12–14].
Additionally, D5D activity strongly influences the PUFA status [15], particularly blood lev-
els of EPA, docosahexaenoic acid (DHA, 22:6n-3) and ARA which have been linked to BP [3,
16–18]. N-6 and n-3 LC PUFA can influence BP in several ways as they are precursors of
FADS1 in the association of fatty acids, BMI and blood pressure
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prostaglandins, thromboxanes and oxidation products with BP modulating effects. While high
ARA status has been shown to increase BP [4, 18, 19], n-3 LC PUFA seem to have BP lowering
effects as indicated by several studies [3, 4, 20]. However, results of observational studies
regarding n-3 LC PUFA and BP in children are inconsistent [18, 21, 22].
As polymorphisms in the FADS1 gene are associated with circulating PUFA levels [23–27],
the relation between LC PUFA and BP may be influenced by genetic variation. The single
nucleotide polymorphism (SNP) rs174546 [24] was shown to have strong effects on serum
PUFA levels. Carriers of the rs174546 minor (T) allele showed a reduced activity of D5D
resulting in increased levels of the precursor n-6 PUFA LA and dihomo-gamma-linolenic acid
(DGLA, 20:3n-6) as well as the n-3 precursor PUFA ALA while the n-6 and n-3 D5D products
ARA and EPA were found to be decreased [24]. Several studies suggested that rs174546 plays
an important functional role in the FADS1 gene cluster [24, 27, 28]. Results of the HELENA
study investigating minor alleles of nine SNPs in the FADS gene cluster in a large group of
adolescents suggest that the rs174546 SNP is in linkage disequilibrium with a functional SNP
within FADS1 as all haplotypes carrying the minor allele were associated with lower D5D activ-
ity [24]. Also other studies indicated rs174546 to have a functional role in the FADS1 gene vari-
ants or to be at least an appropriate proxy for a functional but yet unknown FADS1 variant
[27, 28]. Thus, we hypothesize that genetic variation in the FADS1 rs174546 influences BP via
whole blood PUFA levels and BMI as mediators, and we investigate the direct and indirect
effects on BP applying path analysis.
Methods
Study population
The IDEFICS (Identification and prevention of dietary- and lifestyle-induced health effects in
children and infants) baseline survey (T0) included a population-based sample of 16,228 chil-
dren aged 2 to 9.9 years from eight European countries (Belgium, Cyprus, Estonia, Germany,
Hungary, Italy, Spain, Sweden) who were examined in 2007/2008. Follow-up examinations
were conducted after two (T1) and six (T3, I.Family study) years; the design of this cohort
study has been described in detail elsewhere [29, 30]. However, in this study, only cross-sec-
tional data from the IDEFICS baseline survey were included as only at T0 a large number of
children with FA data was available. In the IDEFICS study risk factors of overweight and obe-
sity were investigated in young children and anthropometric and clinical examinations were
conducted at each survey wave. Additionally, health characteristics and lifestyle behaviours
were collected and biosamples were taken. Parents gave written informed consent prior to
study participation and children gave oral consent prior to the examinations. All participating
centers obtained ethical approval by the regional committees: Tallinn Medical Research Ethics
Committee, Tallinn, Estonia; Ethics Committee of the University of Bremen, Bremen, Ger-
many; Ege´szse´gu¨gyi Tudoma´nyos Tana´cs, Pe´cs, Hungary; Azienda Sanitaria Locale Avellino
Comitato Etico, Avellino, Italy; Regionala Etikpro¨vningsna¨mnden i Go¨teborg, Gothenburg,
Sweden; Comite´ E´tico de Investigacio´n Clı´nica de Arago´n, Zaragoza, Spain.
Genotyping and quality control (QC) of SNP data
Genomic DNA was extracted from saliva samples. Genotyping was conducted using the UK
Biobank Axiom1 96-Array from Affymetrix (Santa Clara, USA). Genotype calling was per-
formed with respect to Affymetrix’s best practice guideline including analysis with SNPolisher
assuming a dish QC > 0.82 and QC call rate > 0.97. 40 individuals were excluded for sample
call rate 0.98, ambiguous sex assignments, heterozygosity or as population outliers assessed
by principal component analysis [31, 32].
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An additive effect was assumed, with 0, 1, or 2 encoding the number of minor allele T pres-
ent at SNP rs174546. The analyses were limited to FADS1 as no genetic data on FADS2 was
available.
Fatty acids
In a subsample of 2600 IDEFICS participants with an oversampling of overweight and obese
children, FA profiles were analyzed [29]. Blood samples were obtained by collecting a drop of
fasting blood from a fingertip or by venipuncture and were applied directly to an antioxidant-
treated paper strip. FA in whole blood were separated and determined by a rapid gas-liquid
chromatography method in a central laboratory as previously described [33, 34]. This method
was validated by several laboratories [34–36] and whole blood was shown to be representative
for the total FA pool as it includes FA from all lipid classes with phospholipids of plasma and
red blood cells (RBC) being the main contributors of the FA amount and profile [35]. Several
studies confirmed that whole blood is a suitable marker for n-3 FA status and for long-term
essential FA intake [34, 37, 38].
In the present analysis we used FA values of the n-3 PUFA, EPA and the n-6 PUFA, DGLA
and ARA. FA are expressed as weight percentage of all FA detected (% wt/wt). Additionally,
we calculated the D5D index from the product-precursor ratio (20:4n-6/20:3n-6).
Blood pressure
A standardized protocol was used to measure systolic (SBP) and diastolic (DBP) BP with an
automated oscillometric device (Welch Allyn, Inc., 4200B-E2, Skaneateles Falls, NY, USA)
after at least 5 minutes of rest in seated position at the right arm with a cuff of appropriate size
for arm circumference [39]. Two recordings were taken, with a 2-min interval between each,
plus a third measurement in case of a>5% difference between the first two readings. As out-
come measure the mean value of the two measurements with the smallest difference was used.
BP was set to missing if the first and second measurement deviated by>5% and no third mea-
surement value was available. Age, sex and height specific reference values from the US
Department of Health and Human Services, National Institutes of Health (NIH, 2005) [40]
were applied to classify SBP, DBP and BP to normal BP, prehypertension and hypertension.
Based on the NIH references age-, sex- and height-specific z-scores were calculated and used
as outcome variables in the subsequent analysis.
BMI
Body weight was measured in light underwear in fasting state on a calibrated scale accurate to
0.1 kg (Tanita BC 420 MA Tanita Europe GmbH, Sindelfingen, Germany). A calibrated stadi-
ometer (Seca 225 stadiometer, Birmingham, UK) was used to measure height of the children
to the nearest 0.1 cm. BMI was calculated as weight [kg] divided by height [m] squared and
BMI z-scores were calculated based on Cole & Lobstein (2012) [41].
Covariates. Covariate data such as date of birth, dietary and lifestyle behaviors and socio-
economic information were assessed using questionnaires. In a personal interview the family
history of diseases and the health conditions of the participating child were collected.
Sex of the child, age (continuous), country (six countries as categories: Estonia, Germany,
Hungary, Italy, Spain, Sweden), maximum educational level of parents according to the Inter-
national Standard Classification of Education (ISCED) [42] (three categories: low level, ISCED
0, 1 and 2; medium, ISCED 3 and 4; high, ISCED 5 and 6), sedentary behaviour (television and
computer time (hours/week)), family history of hypertension (yes vs. no; as reported for bio-
logical parents/siblings) and birth weight (g) were considered as covariates. As indicator of
FADS1 in the association of fatty acids, BMI and blood pressure
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dietary salt intake we used the weekly frequency of salty/snack food consumption which
includes hamburger, hot dog, kebab, wrap, salty snacks such as savory pastries and fritters as
well as cold cuts and ready to cook meat products. Further, the consumption frequency of fish
(times/week) was considered in all analyses including EPA.
The weight percentages of our focus PUFA vary individually also depending on the propor-
tions of the different lipid classes (phospholipids, triacylglycerols and cholesterylesters) in
plasma, RBC, HDL and LDL. As total saturated (SFA) and total monounsaturated FA (MUFA)
are the major FA with different distributions in these lipid classes [35], also weight percentages
of SFA and MUFA of total FA were included as covariates. Their inclusion in the models aims
to adjust for the different proportions of lipid classes. Additionally, we included blood levels of
triglycerides (TG) and low-density lipoprotein cholesterol (LDL) as covariates. TG were directly
measured with the ‘point-of-care analyser’ Cholestech LDX (Cholestech, Hayward, CA, USA)
while LDL was calculated from Cholestech data as previously described [43].
Analysis group
Among the children with FA analyses (N = 2600), 10 children were excluded because of blood
drawing in a non-fasting state and further 406 children had to be excluded due to missing BP
or missing covariate data resulting in 2184 children. No genetic data was available for 1664
children, leaving 520 children in the final analysis sample (Fig 1).
Statistical analyses
Path analysis was used to test a theory-driven model linking FADS1 to blood pressure medi-
ated by effects on FA and BMI. Path analysis has the advantage over linear regression that path
coefficients are estimated via simultaneous equation estimation, thus adjusting standard errors
for the number of equations computed [44]. These models further allow the estimation of
total, direct and indirect effects. The structure of our theoretical model is displayed in Fig 2.
The arrows in Fig 2 represent direct effects which are independent of the other variables in
the path model. Additionally, there are indirect effects which influence a variable via an inter-
mediate variable (not presented in Fig 2) [45]. This means that FADS1 was assumed to affect
BP directly but also indirectly through FA status (or D5D index) and BMI that lie on paths
between FADS1 and BP. The FA status (or D5D index) was assumed to affect BP directly as
well as via BMI and the BMI was assumed to directly affect BP. Separate models were run for
the two outcomes SBP and DBP as well as for the four exposures (1) DGLA, (2) ARA, (3) EPA
and (4) D5D. Models 1a to 4a refer to the four models run for SBP, models 1b to 4b to the four
models run for DBP, respectively. The covariates mentioned above were considered in the
analyses (see S1 Table for a more detailed description of the covariates being related to the dif-
ferent endogenous (outcome) variables in the model). After running the a priori defined path
model, the following model modifications were applied based on both theoretical consider-
ations and model fit indices: covariances among residual terms, among country indicators and
sex, among sex and age, sex and educational level of parents, educational level of parents and
age, educational level of parents and SNP genotypes, SNP genotypes and age, SNP genotypes
and media time as well as birth weight and media time were set to zero. Based on fit indices,
also some changes in the covariates affecting the three endogenous variables BP, BMI and FA
were applied if biologically plausible as summarized in S1 Table. For parameter estimation, we
used the maximum-likelihood procedure with quasi-Newton optimization. A non-significant
Chi-square test (P>0.05), Comparative Fit Index (CFI)0.97, and Root Mean Square Error of
Approximation (RMSEA)0.03 indicated a very good model fit in all models estimated [46].
FADS1 in the association of fatty acids, BMI and blood pressure
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Mediation was assessed by computing estimates of direct, indirect, and total effects of the
associations specified in the model. Direct effects represent associations between variables
unmediated by any other variable in the model. Indirect effects represent mediated effects (or
combined mediated effects for paths through multiple mediators). Total effects are the sum of
the direct and indirect effects. For all models, standardized path coefficients and corresponding
Fig 2. Theoretical models displaying the direct effects in proposed pathways through which BP (SBP
or DBP, respectively) is affected by the SNP (rs174546), by fatty acids (DGLA, ARA, EPA, D5D index)
as well as by BMI.
https://doi.org/10.1371/journal.pone.0181485.g002
Fig 1. Flow chart of the inclusion and exclusion of IDEFICS participants.
https://doi.org/10.1371/journal.pone.0181485.g001
FADS1 in the association of fatty acids, BMI and blood pressure
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p-values are reported. Following the proposal by Cribbie (2007) [47] of how to account for mul-
tiple testing problems in pathway analysis, the adjustment method by Benjamini & Hochberg
(1995) [48] was applied to control for the false discovery rate (FDR) at the 0.05 level of signifi-
cance. Multiple comparison adjustment was applied for each outcome (SBP and DBP) and each
research question resulting in different adjusted alpha levels which are indicated in the respec-
tive result table. All analyses were performed using SAS1 statistical software version 9.3 (SAS
Institute, Inc., Cary, NC). All path models were run using SAS Proc CALIS.
Results
Table 1 gives a description of the total study group by blood pressure category. Children classi-
fied as hypertensive had a higher mean BMI z-score, a lower mean birth weight and a higher
mean consumption frequency of salty/snack food compared with normotensive children.
Table 2 shows the characteristics of the study population by rs174546 genotypes. The SNP was
in Hardy-Weinberg Equilibrium (p = 0.395) and minor allele frequency for rs174546 was 29%.
About 9% of children were homozygous and about 40% were heterozygous carriers of the
minor allele.
Pairwise correlations among the SNP, PUFA, BMI z-score, SBP z-score and DBP z-score
are displayed in Table 3. Significant positive correlations were observed between BMI z-score
and SBP z-score, DGLA and ARA. DGLA was positively correlated with the SNP. In contrast,
the number of T alleles at SNP rs174546 correlated inversely with ARA and D5D index.
Table 4 shows the estimated direct and indirect effects obtained from the different path
models to disentangle the associations among BP z-score, BMI z-score, the FA and D5D index
as well as the SNP rs174546. Models 1a to 4a present the results obtained for SBP with regard
to DGLA (model 1a), ARA (model 1b), EPA (model 1c) and D5D (model 1d), and models 1b
to 4b present the respective results for DBP. Standardized direct as well as indirect effects are
displayed according to the defined path model. As expected, rs174546 showed significant
direct effects on all FA levels and D5D index being positive for DGLA and negative for ARA,
EPA and D5D index. The direct effects of the SNP on BMI were negative in all models but
reached statistical significance only in the models for DGLA and for the D5D index. Neither
the SNP nor the FA or D5D index showed a direct effect on SBP or DBP in any of the models.
A direct effect on SBP and DBP was only observed for the BMI z-score. DGLA and EPA
showed a positive direct effect on BMI.
SNP rs174546 revealed a positive indirect effect on BMI via DGLA. A negative indirect
effect of the SNP on SBP via ARA and BMI was observed. Fig 3 presents the estimated direct
effects which are independent of mediating variables between the SNP rs174546, ARA, BMI
and SBP. The largest effect observed was between BMI and SBP indicating that a higher BMI
was associated with an increase in SBP. Further, there was a strong negative effect of the SNP
on ARA indicating that in minor allele carriers the conversion from DGLA to ARA is reduced.
As can be seen from Fig 3, the negative indirect effect between the SNP and SBP results from
the negative direct effects of the SNP on ARA as well as on BMI overlaying the positive direct
effects of ARA and the BMI on SBP.
DGLA and EPA had a positive indirect effect on SBP via BMI. The observed indirect effects
on SBP point to the same directions for DBP.
The positive direct effect of EPA on BMI was unexpected and previous analyses indicated
that the association of the EPA status with BP may depend on weight status [18]. Therefore,
an additional analysis was conducted assessing the direct effects of EPA on BMI z-score and
BP z-scores and the indirect effects of EPA on BP z-scores through BMI z-score separately for
thin/normal weight versus overweight/obese children. This was done by use of respective
FADS1 in the association of fatty acids, BMI and blood pressure
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interaction terms between weight status and EPA in the path model. The results are displayed
in Table 5. EPA had a direct negative effect on BMI in thin/normal weight children whereas a
positive effect was observed in overweight/obese children. The direct and indirect effects of
EPA on BP point to the same directions, i.e. were negative in thin/normal weight children and
positive in overweight/obese children.
Table 1. Baseline characteristics of the study population by blood pressure category[1].
All
n = 520
Normal BP n = 425 Pre-hypertension n = 51 Hypertension n = 44
Sex, n (%) Girls 260 (50.0) 214 (50.4) 21 (41.2) 25 (56.8)
Boys 260 (50.0) 211 (49.6) 30 (58.8) 19 (43.2)
Age, years Mean (SD) 6.45 (1.67) 6.52 (1.59) 5.69 (1.85) 6.67 (2.08)
2-<6 years, n (%) 177 (34.0) 138 (32.5) 26 (51.0) 13 (29.5)
6-<10 years, n (%) 343 (66.0) 287 (67.5) 25 (49.0) 31 (70.5)
BMI, Mean (SD)[2] z-score 0.88 (1.27) 0.82 (1.26) 0.79 (1.33) 1.59 (1.10)
BMI category, n (%)[2] Thin 29 (5.6) 26 (6.1) 2 (3.9) 1 (2.3)
Normal weight 287 (55.2) 247 (58.1) 26 (51.0) 14 (31.8)
Overweight 121 (23.3) 92 (21.6) 15 (29.4) 14 (31.8)
Obese 83 (16.0) 60 (14.1) 8 (15.7) 15 (34.1)
FADS1 rs174546, CC 266 (51.2) 220 (51.8) 26 (51.0) 20 (45.5)
n (%) CT 206 (39.6) 165 (38.8) 22 (43.1) 19 (43.2)
TT 48 (9.2) 40 (9.4) 3 (5.9) 5 (11.4)
BP, Mean (SD) SBP, z-score 0.41 (0.78) 0.19 (0.60) 0.94 (0.49) 1.89 (0.63)
DBP, z-score 0.63 (0.59) 0.46 (0.46) 1.24 (0.38) 1.56 (0.60)
PUFA, % wt/wt, Mean (SD) 18:2n-6, LA 17.9 (2.01) 17.9 (1.97) 17.3 (1.83) 18.1 (2.47)
20:3n-6, DGLA 1.22 (0.25) 1.22 (0.25) 1.23 (0.26) 1.24 (0.25)
20:4n-6, ARA 7.53 (1.34) 7.50 (1.31) 7.70 (1.33) 7.70 (1.66)
18:3n-3, ALA 0.20 (0.08) 0.20 (0.08) 0.19 (0.09) 0.20 (0.08)
20:5n-3, EPA 0.27 (0.11) 0.27 (0.11) 0.25 (0.09) 0.31 (0.13)
22:6n-3, DHA 1.20 (0.45) 1.18 (0.44) 1.18 (0.42) 1.35 (0.48)
D5D index, Mean (SD) 20:4n-6/20:3n-6 6.32 (1.29) 6.31 (1.30) 6.44 (1.18) 6.31 (1.35)
SFA, % wt/wt, Mean (SD) sum 44.5 (1.93) 44.5 (1.95) 44.6 (1.96) 43.9 (1.66)
MUFA, % wt/wt, Mean (SD) sum 25.1 (2.38) 25.0 (2.35) 25.3 (2.29) 24.9 (2.72)
Family history of hypertension, n (%) no 413 (79.4) 341 (80.2) 39 (76.5) 33 (75.0)
yes 107 (20.6) 84 (19.8) 12 (23.5) 11 (25.0)
Parental education,
ISCED level,
n (%) Level 0, 1, 2 57 (11.0) 47 (11.1) 6 (11.8) 4 (9.1)
Level 3, 4 297 (57.1) 244 (57.4) 28 (54.9) 25 (56.8)
Level 5, 6 166 (31.9) 134 (31.5) 17 (33.3) 15 (34.1)
Birth weight, Mean (SD) g 3352 (537) 3369 (531) 3303 (624) 3254 (488)
Consumption frequency of salty/snack food,
Mean (SD)
times per week 5.34 (4.70) 5.24 (4.62) 5.55 (5.22) 6.11 (4.84)
Time spent with audiovisual media, Mean (SD) hours per week 12.0 (7.70) 12.0 (7.81) 11.6 (6.76) 12.1 (7.77)
[1]National Institutes of Health 2005
[2]Cole & Lobstein 2012
ARA, arachidonic acid; ALA, alpha-linolenic acid; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; DHA, docosahexaenoic acid;
DGLA, dihomo-gamma-linolenic acid; EPA, eicosapentaenoic acid; ISCED, International Standard Classification of Education; LA, linoleic acid; MUFA,
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SBP, systolic blood pressure; SD, standard deviation; SFA, saturated fatty acids; % wt/wt,
weight percentage of all fatty acids detected.
https://doi.org/10.1371/journal.pone.0181485.t001
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Discussion
Our study in European children revealed that carrying the minor (T) variant of SNP rs174546,
lying in the FADS1 gene, has a favorable indirect effect on SBP via ARA in an analysis based
on path models. However, no direct effect of the T allele on BP was observed. This indirect
effect results from various countervailing direct effects via the blood level of ARA and the BMI
z-score. The SNP was associated with lower ARA levels and this association may have overlaid
the positive associations of ARA and the BMI with SBP in our model. To our knowledge this is
the first study showing that the investigated FADS1 SNP has a beneficial effect on SBP via its
negative effects on the ARA level and on BMI z-score. This is in line with previous findings
indicating that high ARA is associated with elevated BP in adults [4, 19] and, as observed in
our recent analysis, also in children [18]. As expected, we observed strong negative effects of
the SNP on ARA because in minor allele carriers the D5D-mediated conversion from DGLA
to ARA is reduced. Further, the BMI z-score showed the expected positive association with BP.
While we observed a beneficial indirect effect of the SNP via ARA and the BMI on SBP, the
direct association of the SNP with SBP indicated a positive direction which was not statistically
significant (0.077, p = 0.085; total effect: 0.020, p = 0.641). Also the direct effects of ARA on
BMI and the direct effects of ARA as well as BMI on SBP pointed to a positive direction
although only the latter was statistically significant. The opposite direct effect of the SNP on
SBP may result from factors not considered in the respective model which could have been
influenced by the SNP, like the levels of other FA, e.g. decreased DHA [26] or increased insulin
levels [6] in minor allele carriers, both of which can contribute to BP elevation [3, 16, 49].
For DGLA, EPA and D5D index, the indirect effects also pointed to a negative direction
indicating a beneficial effect of the SNP though not being statistically significant. For DGLA, a
beneficial indirect effect of the SNP on BP would be unlikely as more DGLA is available in
minor allele carriers and DGLA had a positive indirect effect on BP in our study via BMI and
was positively associated with BP in previous studies [17, 50, 51]. Additionally, high DGLA
Table 2. Baseline characteristics of the study population by FADS1 genotype.
FADS1 rs174546
CC CT TT
All n (%) 266 (51.2) 206 (39.6) 48 (9.2)
Sex, n (%) Girls 118 (45.4) 115 (44.2) 27 (10.4)
Boys 148 (56.9) 91 (35.0) 21 (8.1)
Age, years Mean (SD) 6.45 (1.67) 6.52 (1.65) 6.13 (1.77)
2-<6 years, n (%) 89 (50.3) 68 (38.4) 20 (11.3)
6-<10 years, n (%) 177 (51.6) 138 (40.2) 28 (8.2)
BMI, Mean (SD)[1] z-score 0.95 (1.29) 0.82 (1.24) 0.73 (1.26)
BP, Mean (SD) SBP, z-score 0.35 (0.76) 0.47 (0.81) 0.44 (0.71)
DBP, z-score 0.62 (0.59) 0.63 (0.58) 0.71 (0.60)
PUFA, % wt/wt, Mean (SD) 18:2n-6, LA 17.5 (1.86) 18.2 (2.13) 18.5 (1.89)
20:3n-6, DGLA 1.16 (0.23) 1.25 (0.22) 1.43 (0.33)
20:4n-6, ARA 7.81 (1.33) 7.34 (1.34) 6.88 (1.06)
18:3n-3, ALA 0.19 (0.07) 0.21 (0.09) 0.21 (0.10)
20:5n-3, EPA 0.27 (0.11) 0.26 (0.11) 0.25 (0.09)
22:6n-3, DHA 1.22 (0.45) 1.18 (0.45) 1.13 (0.40)
D5D index, Mean (SD) 20:4n-6/20:3n-6 6.86 (1.18) 5.94 (1.08) 4.98 (1.11)
[1]Cole & Lobstein 2012
https://doi.org/10.1371/journal.pone.0181485.t002
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levels result in a lower D5D index which is the ratio of ARA and DGLA. The D5D index has
shown to be inversely associated with BP in adults [6, 52]. Therefore, one may hypothesize that
there is a positive association of rs174546 with BP via D5D index as minor allele carriers had a
lower D5D index. However, because of the expected and observed strong negative direct effect
of the SNP on the D5D index together with its negative direct effect on BMI, the resulting indi-
rect effect of the SNP on SBP via D5D index and BMI pointed to a negative direction.
Additionally, our results suggest a positive indirect effect of the SNP on BMI via DGLA.
The latter result is in line with a study in adolescents indicating a positive association of DGLA
and BMI [53].
Contrary to our expectations, there was no significant indirect effect of the common
FADS1 SNP on BP via EPA and BMI. The SNP was assumed to be positively associated
with BP via EPA as in children with minor alleles, EPA biosynthesis is reduced. High EPA
levels were shown to be protective against hypertension in previous studies in adults [3, 4]
although results in children are inconsistent [18, 21, 22]. In our model, EPA unexpectedly
showed a direct positive effect on BMI and an indirect positive effect on SBP via BMI.
However, a subgroup analysis revealed that the direct effect of EPA on BMI was only pres-
ent in overweight/obese children whereas in thin/normal weight children the expected
negative effect was observed. The indirect effect of EPA on BP also pointed to a positive
effect in overweight/obese children but to a negative effect in thin/normal weight children.
Thus, the unexpected effects of EPA are likely to result from effect modification by weight
status. Also in a recent study, we found a beneficial effect of EPA on BP only in thin/nor-
mal weight children whereas an unfavorable association was observed in overweight/obese
children [18]. We did not consider DHA in our analyses as the conversion efficiency from
ALA and EPA to DHA is very low [54, 55] and we were particularly interested in the SNP’s
influence on endogenous synthesis via FADS1 and the effects on BP in this analysis. Addi-
tionally, in previous analyses no statistically significant effect of DHA on BP was observed
neither in the total sample nor in an analysis stratified by weight status [18].
Table 3. Pearson correlation coefficients and p-values among SBP, DBP, BMI z-score, FA and D5D index and the SNP.
SBP z-score DBP z-score BMI z-score DGLA ARA EPA D5D rs174546
SBP z-score 1.00
DBP z-score 0.62 1.00
< .0001
BMI z-score 0.28 0.04 1.00
< .0001 0.360
DGLA 0.04 -0.08 0.23 1.00
0.365 0.060 < .0001
ARA 0.05 -0.05 0.21 0.44 1.00
0.294 0.284 < .0001 < .0001
EPA 0.04 0.09 -0.02 -0.08 -0.04 1.00
0.387 0.040 0.693 0.060 0.384
D5D -0.02 0.04 -0.04 -0.60 0.42 0.05 1.00
0.738 0.356 0.410 < .0001 < .0001 0.266
rs174546* 0.07 0.04 -0.04 0.27 -0.22 -0.09 -0.48 1.00
0.120 0.420 0.328 < .0001 < .0001 0.041 < .0001
*Spearman correlation
Bold figures indicate a false discovery rate (FDR) <0.05 for reported correlations. An FDR adjusted significance value corresponds to αadj = 0.017.
https://doi.org/10.1371/journal.pone.0181485.t003
FADS1 in the association of fatty acids, BMI and blood pressure
PLOS ONE | https://doi.org/10.1371/journal.pone.0181485 July 21, 2017 10 / 17
As reported in previous studies [23–27], our results confirm for the n-6 PUFA that the SNP
directly affects the FA levels indicating that minor allele carriers had higher levels of precursor
(DGLA) and lower levels of product FA (ARA) whereas for n-3 PUFA this effect is less obvi-
ous. This was also reflected by a negative effect on the D5D index in our study.
The rs174546 SNP has also shown to influence lipoprotein profiles as T allele carriers have
lower cholesterol levels [56, 57]. Additionally, LDL and TG have been shown to influence the
association between BMI and BP [58] and were hence included as covariates in the models.
FADS1 gene variants and cardiovascular diseases (CVD) or stroke for which hypertension is a
major risk factor suggested a role of the rs174546 SNP. In a Chinese case-control study, the
rs174546 T allele was found to be associated with an increased risk of coronary artery disease
and ischemic stroke while the CC/CT genotypes were associated with a decreased risk [28]. In
Table 4. Standardized estimates of direct and indirect effects and corresponding p-values obtained from path analyses for the associations
among systolic/diastolic blood pressure z-score, BMI z-score, the FA and D5D index and the SNP rs174546.
DGLA (20:3n-6) ARA (20:4n-6) EPA (20:5n-3) D5D index
Coefficient p-value Coefficient p-value Coefficient p-value Coefficient p-value
SBP Model 1a Model 2a Model 3a Model 4a
Direct effects on FA*
rs174546 0.353 < .0001 -0.237 < .0001 -0.092 0.016 -0.527 < .0001
Direct effects on BMI
FA* 0.164 0.001 0.076 0.243 0.147 0.001 -0.097 0.040
rs174546 -0.134 0.002 -0.058 0.167 -0.061 0.122 -0.125 0.007
Direct effects on SBP
BMI 0.288 < .0001 0.282 < .0001 0.284 < .0001 0.291 < .0001
FA* -0.002 0.968 0.149 0.040 0.027 0.576 0.035 0.482
rs174546 0.043 0.352 0.077 0.085 0.044 0.288 0.061 0.217
Indirect effects
rs174546 —> FA* —> BMI 0.058 0.002 -0.018 0.247 -0.014 0.052 0.051 0.042
rs174546 —> FA* —> BMI—> SBP -0.023 0.328 -0.057 0.007 -0.024 0.060 -0.040 0.170
FA* —> BMI—> SBP 0.047 0.004 0.021 0.251 0.042 0.004 -0.028 0.051
DBP Model 1b Model 2b Model 3b Model 4b
Direct effects on FA*
rs174546 0.353 < .0001 -0.237 < .0001 -0.092 0.016 -0.527 < .0001
Direct effects on BMI
FA* 0.164 0.001 0.076 0.243 0.147 0.001 -0.097 0.040
rs174546 -0.134 0.002 -0.058 0.167 -0.061 0.122 -0.125 0.007
Direct effects on DBP
BMI 0.139 0.002 0.134 0.003 0.134 0.003 0.141 0.002
FA* -0.003 0.954 0.103 0.158 0.031 0.512 0.036 0.481
rs174546 -0.006 0.904 0.017 0.698 -0.004 0.922 0.012 0.804
Indirect effects
rs174546 —> FA* —> BMI 0.058 0.002 -0.018 0.247 -0.014 0.052 0.051 0.042
rs174546 —> FA*—> BMI—> DBP -0.012 0.587 -0.035 0.061 -0.013 0.091 -0.029 0.291
FA* —> BMI—>DBP 0.023 0.028 0.010 0.278 0.020 0.029 -0.014 0.087
*FA is a place holder for the fatty acids and D5D index being considered in the different models as given in the headline of the table, i.e. DGLA, ARA, EPA
and D5D index, respectively.
Bold figures indicate a false discovery rate (FDR) <0.05 for reported effects on SBP and DBP, respectively. An FDR adjusted significance value
corresponds to αadj = 0.023 and αadj = 0.018, respectively.
https://doi.org/10.1371/journal.pone.0181485.t004
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a large Danish study including more than 24,032 participants with 2648 CVD cases during 14
years of follow-up, no effect of rs174546 on CVD risk in the total study group was observed.
However, among participants homozygous for the minor T allele of rs174546, subjects with a
higher dietary intake of the n-3 FA ALA and a higher ratio of ALA to the n-6 FA LA tended to
be at lower risk for CVD and ischemic stroke [59]. This may indicate a protective effect of the
resulting higher EPA/ARA ratio. In our study the SNP had a negative effect on SBP via lower
ARA. The observed trend for a negative effect of the SNP on SBP via EPA in the total study
group depended on the weight status and indicated a protective role of EPA only in thin/nor-
mal weight children. The effects of variants of a common FADS1 SNP on BP as shown in our
study are one element that has to be considered in the complex association of n-6 and n-3 LC
PUFA with cardiovascular risk factors.
Limitations and strengths
Intrinsic variability of BP could not be considered in our study because repeated BP measure-
ments could be taken only on a single occasion on the examination day. This may have led to
Fig 3. Path model for the associations between the SNP rs174546 and SBP z-score via ARA and BMI z-
score: Standardized direct effects and p-values.
https://doi.org/10.1371/journal.pone.0181485.g003
Table 5. Standardized estimates of direct effects of EPA on BMI z-score and SBP z-score/DBP z-score and indirect effects of EPA on SBP z-score/
DBP z-score via BMI z-score in thin/normal weight versus overweight/obese children obtained from path analyses.
Thin/normal weight
n = 316
Overweight/Obese
n = 204
SBP Coefficient p-value Coefficient p-value
Direct effects on SBP
EPA -0.042 0.568 0.155 0.039
Direct effects on BMI
EPA -0.206 < .0001 0.535 < .0001
Indirect effects
EPA—> BMI—> SBP -0.029 0.060 0.075 0.040
DBP
Direct effects on DBP
EPA -0.023 0.756 0.143 0.058
Direct effects on BMI
EPA -0.206 < .0001 0.535 < .0001
Indirect effects
EPA—> BMI—>DBP -0.002 0.860 0.006 0.860
Bold figures indicate a false discovery rate (FDR) <0.05 for reported effects on SBP and DBP, respectively. An FDR adjusted significance value
corresponds to αadj = 0.025 for both models.
https://doi.org/10.1371/journal.pone.0181485.t005
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an overestimation of BP values [40, 60]. As we had no reliable information on dietary sodium
intake, we used the intake frequency of salty/snack foods as a proxy for sodium intake. These
and other processed foods have shown to be the main source of salt [61]. As absolute quantita-
tive data of FA were not available we included weight percentages of SFA and MUFA of total
FA as covariates to adjust for the different proportions of lipid classes.
As all data were measured cross-sectionally in the present study, thus causality cannot be
determined.
Important strengths of our study are the pan-European analysis sample of 520 children as
well as the detailed phenotyping of the children. In all countries standardized protocols for
data assessment, measurements and biosampling were applied and adherence to protocols was
verified by central quality control. To investigate the association of the SNP and BP in children
can be an advantage as the genetic basis may be stronger compared to adults because of the
accumulation of behavioral and lifetime exposures in older indviduals [62, 63].
Conclusions
Our results indicate that genetic variation in the FADS1 gene, rs174546, influences BP via ARA
and BMI. Thus, polymorphisms with an impact on the D5D activity may play a role for the BP
level mediated through PUFA and BMI. Therefore, health effects of dietary n-6 and n-3 PUFA
may vary depending on genetic FADS1 variants and—considering the observed effect modifi-
cation—on weight status. Different dietary intake recommendations for LC PUFA may be
required according to genotype and weight status.
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